Metropolis Healthcare Shows Stronger Earnings Momentum

is showing a meaningful improvement in its fundamental trajectory, supported by stronger revenue growth, better operating leverage and healthy profitability across its diagnostics business. The latest Q1 FY27 numbers also continued the growth trend, with consolidated revenue rising to roughly ₹455 crore and net profit reaching nearly ₹57 crore. Overall, the combination of higher testing volumes, specialty diagnostics, expanding reach and improving margins provides a constructive fundamental backdrop for the stock. On the technical front, Metropolis Healthcare is developing a well-defined ascending triangle on the daily chart, a structure that generally reflects a gradual shift in control towards buyers. The stock has repeatedly approached the ₹580–₹595 region, creating a relatively flat resistance zone, while the successive higher lows form a clearly rising support trendline. This combination suggests that sellers are finding it increasingly difficult to push the price back to previous lows, while buyers continue to absorb supply on declines. The recent move towards the upper boundary, accompanied by a strong daily advance, keeps the setup constructive and raises the probability of a breakout attempt. A sustained close above ₹595 would provide confirmation of the pattern and could open the way towards the ₹640–₹660 zone, subject to momentum and volume confirmation. On the downside, ₹535–₹540 remains an important immediate support area, while the rising trendline around the ₹450–₹460 region represents the broader structural support.